Maverick Capital’s Caribou Biosciences CRBU Stock Holding History

Maverick Capital’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.24M	Hold	652,542	–	–	0.01%	120
2025 Q4	$1.04M	Hold	652,542	–	–	0.01%	161
2025 Q3	$1.52M	Hold	652,542	–	–	0.02%	181
2025 Q2	$822K	Hold	652,542	–	–	0.01%	184
2025 Q1	$596K	Hold	652,542	–	–	0.01%	198
2024 Q4	$1.04M	Hold	652,542	–	–	0.02%	126
2024 Q3	$1.28M	Hold	652,542	–	–	0.02%	181
2024 Q2	$1.07M	Hold	652,542	–	–	0.02%	209
2024 Q1	$3.35M	Hold	652,542	–	–	0.06%	70
2023 Q4	$3.74M	Hold	652,542	–	–	0.08%	60
2023 Q3	$3.12M	Hold	652,542	–	–	0.07%	55
2023 Q2	$2.77M	Hold	652,542	–	–	0.06%	87
2023 Q1	$3.46M	Hold	652,542	–	–	0.09%	59
2022 Q4	$4.1M	Hold	652,542	–	–	0.1%	63
2022 Q3	$6.88M	Hold	652,542	–	–	0.16%	55
2022 Q2	$3.54M	Hold	652,542	–	–	0.09%	75
2022 Q1	$5.99M	Hold	652,542	–	–	0.11%	71
2021 Q4	$9.75M	Sell	652,542 -300,000	-31%	-$5.83M	0.11%	74
2021 Q3	$21.8M	Buy	+952,542	New	+$23.3M	0.22%	64

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Maverick Capital's CRBU Position: Q1 2026 in Review

Maverick Capital held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 652,542 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #120.

Maverick Capital first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $21.8M in Q3 2021. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

Maverick Capital held 652,542 shares of Caribou Biosciences worth $1.24M as of Q1 2026.
Maverick Capital left its Caribou Biosciences share count unchanged in Q1 2026.
Caribou Biosciences made up 0.01% of Maverick Capital's portfolio in Q1 2026, its #120 holding.
Maverick Capital first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
Maverick Capital's Caribou Biosciences position peaked at $21.8M in Q3 2021.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.